NRC Calls For Submissions On ‘First Of A Kind’ Production Facility :: The Independent Global Nuclear News Agency: The US nuclear regulator has published in the Federal Register a notice of opportunity for submissions regarding a “first of a kind” application by Shine Medical Technologies to operate a proposed medical isotope production facility that does not require a nuclear reactor.
The Nuclear Regulatory Commission said submissions must be filed by 10 March 2020 by anyone who wishes to participate in the hearing process for the application.
Shine has proposed to construct and operate a facility in Janesville, Wisconsin for the production of the radioisotope molybdenum-99 (Mo-99) through the irradiation and processing of a uranyl sulfate solution. The company said this patented process replaces a nuclear reactor with a low-energy, accelerator-based neutron source.
Michele Kearney's Nuclear Wire - Major Energy and Environmental News and Commentary affecting the Nuclear Industry. Nuclear Activities
No comments:
Post a Comment